Doximity (DOCS) heads into Q1 earnings with revenue growth expected to slow

Doximity (DOCS) is expected to report fiscal first-quarter earnings after the market close on May 20, 2026, with Wall Street projecting revenue growth of 4.8% from a year earlier, down from 17.1% growth in the year-ago quarter. The medical professional network reported $185.1 million in revenue last quarter, up 9.8% year over year and ahead of analyst estimates. However, its next-quarter revenue and EBITDA guidance missed expectations by a wide margin. Analyst estimates have largely been unchanged over the past 30 days. Doximity shares have risen 16.3% over the past month, compared with a 17.4% average gain among vertical software peers. The stock recently traded at $26.36, below the average analyst price target of $37.77.